Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$270.75
Used and New from Other Sellers
Used and New from Other Sellers
from $21.98
Usually ships in 1-2 business days
(Save 92%)
Other sellers (Hardcover)
  • All (9) from $21.98   
  • New (7) from $21.98   
  • Used (2) from $59.75   

Overview

Informatics and robotics are the workhorses of a technological revolution in drug research. On them are based combinatorial chemistry, which yields compounds by the many thousands, and high-throughput bioassays, which screen them for activity. The results are avalanches of 'hits', which invade the databases like swarms of locusts. But far from being a plague, these innumerable compounds become a blessing if properly screened for 'drugability', i.e., for 'drug-like' properties such as good pharmacokinetic (PK) behavior. Pharmacokinetic profiling of bioactive compounds has, thus, become a sine qua non condition for cherry-picking the most promising hits. Just as important, but less visible, are the structure-property and structure-ADME relations, which emerge from PK profiling and provide useful feedback when designing new synthetic series. As a result, the screening, design, and optimization of pharmacokinetic properties has become the bottleneck and a major challenge in drug research. To shorten the time-consuming development and high rate of attrition of active compounds ultimately doomed by hidden pharmacokinetic defects, powerful biological, physicochemical, and computational approaches are being developed, whose objectives are to increase the clinical relevance of drug design and to eliminate as soon as possible compounds with unfavorable physicochemical properties and pharmacokinetic profiles.

The profiling of ADME properties (absorption, distribution, metabolism, and excretion) is the topic of this book. Following the extraordinary success of the previous work ('Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical, and Computational Strategies', Eds. B. Testa, H. van de Waterbeemd, G. Volkers, R. Guy, Verlag Helvetica Chimica Acta, Zürich, 2001, 655 pages), there was a need for an essentially new edition focusing on the latest theoretical and technological breakthroughs. In this unique work, international authorities and practicing experts from academia and industry offer state-of-the-art presentations of concepts, methods and technologies now in use or development in drug research. The biological strategies emphasized in the book include cell cultures, drug-metabolizing enzymes, transporters and plasma protein binding. The physicochemical strategies focus on artificial membrane-permeability assays, on solubility and lipophilicity and related molecular properties as factors and predictors of pharmacokinetic behavior, and on stability and solid-state properties. Computational strategies comprize the exploration of property spaces, pharmacophore searching to predict biotransformation and enzyme inhibition, and expert systems to process biopharmaceutical profiling data.

In addition to its 28 chapters, the book includes a CD-ROM containing the invited lectures, oral communications, and posters (in full version) presented at the Third LogP Symposium, 'Physicochemical and Biological Profiling in Drug Research', held at the Federal Institute of Technology (ETH) of Zürich in March 2004.

Read More Show Less

Product Details

  • ISBN-13: 9783906390352
  • Publisher: Wiley
  • Publication date: 3/31/2006
  • Edition description: BK&CD-ROM
  • Edition number: 1
  • Pages: 500
  • Product dimensions: 6.63 (w) x 10.12 (h) x 1.17 (d)

Table of Contents

Preface
SETTING THE SCENE
Pharmaceutical research: For what, for whom? Science and social policies (D. J. Triggle)
Property-based lead optimization (H. van de Waterbeemd)
PART 2: BIOLOGICAL STRATEGIES
Membranes - from barriers to magic bullets (O. G. Mouritsen)
Cell culture absorption models - state of the art (P. Artursson, P. Matsson)
Metabolic studies in drug research and development (B. Neugnot, M.-J. Bossant, F. Caradec, B. Walther)
In vitro, in vivo and in silico approaches to predict induction of drug metabolism (U. A. Meyer, S. Blättler, C. Gnerre, M. Oscarson, A.-K. Peyer, F. Rencurel, O. Rifki, A. Roth)
Coordination of uptake and efflux transporters in drug disposition (H. Kusuhara, Y. Sugiyama)
The role of plasma protein binding in drug discovery (R. E. Fessey, R. P. Austin, P. Barton, A. M. Davis, M. C. Wenlock)
In vivo pharmacokinetic profiling of drugs (H. Wunderli-Allenspach)
PART 3: PHYSICOCHEMICAL STRATEGIES
Automated parallel synthesis in support of early drug discovery: Balancing accessibility of chemistry with the design of drug-like libraries (C. M. Baldino)
New insights into the lipophilicity of ionized species (G. Caron, G. Ermondi)
Physicochemical and biological profiling in drug research. ElogD(7.4) 20,000 compounds later: refinements, observations and applications (F. Lombardo, M. Y. Shalaeva, B. D. Bissett, N. Chistokhodova)
Lipid bilayers in ADME: Permeation barriers and distribution compartments (S. D. Kr-mer)
High-throughput solubility, permeability, and the MAD PAMPA model (A. Avdeef)
Correlations between PAMPA permeability and log P (K. Box, J. Comer, F. Huque)
Predicting the intestinal solubility of poorly soluble drugs (A. Glomme, J. Mörz, J. B. Dressman)
Accelerated stability profiling in drug discovery (E. H. Kerns, L. Di)
Physicochemical characterisation of the solid state in drug development (D. Giron)
PART 4: COMPUTATIONAL STRATEGIES
Calculation of lipophilicity: A classification of methods (R. Mannhold)
The concept of property space: The case of acetylcholine (G. Vistoli, A. Pedretti, L. Villa, B. Testa)
Prediction of site of metabolism in humans: Case studies of cytochromes P450 2C9, 2D6 and 3A4 (G. Cruciani, R. Vianello, I. Zamora)
Use of pharmacophores in predictive ADME (O. O. Clement, O. F. Gfiner)
The BioPrint? approach for the evaluation of ADME-T properties: Application to the prediction of cytochrome P450 2D6 inhibition (R. Gozalbes, F. Barbosa, N. Froloff, D. Horvath)
Using computer reasoning about qualitative and quantitative information to predict metabolism and toxicity (P. Judson)
Physiologically based pharmacokinetic models (T. Lavé, H. Jones, N. Paquerau, P. Poulin, P. Theil, N. Parrott)
Processing of biopharmaceutical profiling data in drug discovery (K. Sugano, R. Saitoh, A. Higashida, H. Hamada)
PART 5: CONCLUDING CHAPTERS
Educational and communication issues related to profiling compounds for their drug-like properties (R. T. Borchardt)
Present and future significance of ADMET profiling in industrial drug research (W. Cautreels, M. de Vries, C. Häfer, H. Koster, L. Turski)

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)